6 Management of symptomatic thyrotoxicosis in combination with methimazole

مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت

hormonal, intrauterine device or; abstinence prior to study entry, during the study participation, and for six months after the last dose of the drug; women of child bearing potential must have a negative serum pregnancy test within 14 days prior to randomization, cannot be breast feeding, and must agree to use a highly effective form of contraception throughout the treatment period and for 6 months after the last dose of study treatment; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately